These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8709234)

  • 1. Characterization of human immunodeficiency virus type 1 Vif particle incorporation.
    Camaur D; Trono D
    J Virol; 1996 Sep; 70(9):6106-11. PubMed ID: 8709234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function.
    Simon JH; Miller DL; Fouchier RA; Malim MH
    Virology; 1998 Sep; 248(2):182-7. PubMed ID: 9721227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions.
    Sova P; Chao W; Volsky DJ
    Biochem Biophys Res Commun; 1997 Nov; 240(2):257-60. PubMed ID: 9388463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.
    Fouchier RA; Simon JH; Jaffe AB; Malim MH
    J Virol; 1996 Dec; 70(12):8263-9. PubMed ID: 8970945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.
    Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; Strebel K
    J Virol; 2003 Jan; 77(2):1131-40. PubMed ID: 12502829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.
    Khan MA; Aberham C; Kao S; Akari H; Gorelick R; Bour S; Strebel K
    J Virol; 2001 Aug; 75(16):7252-65. PubMed ID: 11461998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.
    Goncalves J; Shi B; Yang X; Gabuzda D
    J Virol; 1995 Nov; 69(11):7196-204. PubMed ID: 7474141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
    Madani N; Kabat D
    J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription.
    Dettenhofer M; Cen S; Carlson BA; Kleiman L; Yu XF
    J Virol; 2000 Oct; 74(19):8938-45. PubMed ID: 10982337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
    Ochsenbauer C; Wilk T; Bosch V
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
    Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K
    J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.
    Gaddis NC; Chertova E; Sheehy AM; Henderson LE; Malim MH
    J Virol; 2003 May; 77(10):5810-20. PubMed ID: 12719574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
    Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
    J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.